$COLL
COLLEGIUM PHARMACEUTICAL, INC Stock $coll

$coll Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000155837022012184 Filed on August 04, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$127.0M	$123.5M	$83.75M
YoY Change	61.1%	48.96%	-4.53%
Cost Of Revenue	$68.17M	$71.19M	$35.26M
YoY Change	108.29%	117.67%	9.75%
Gross Profit	$58.84M	$52.36M	$48.50M
YoY Change	27.6%	4.23%	-12.77%
Gross Profit Margin	46.33%	42.38%	57.9%
Selling, General & Admin	$38.37M	$41.25M	$54.53M
YoY Change	25.75%	35.85%	73.24%
% of Gross Profit	65.22%	78.78%	112.44%
Research & Development	$0.00	$0.00	$3.983M
YoY Change	-100.0%	-100.0%	35.94%
% of Gross Profit	0.0%	0.0%	8.21%
Depreciation & Amortization	$38.04M	$38.16M	$715.0K
YoY Change	120.6%	121.15%	62.87%
% of Gross Profit	64.65%	72.87%	1.47%
Operating Expenses	$38.37M	$41.25M	$58.51M
YoY Change	20.05%	21.95%	70.06%
Operating Profit	$20.47M	$11.11M	-$10.02M
YoY Change	44.65%	-32.29%	-147.26%
Interest Expense	$19.05M	$17.76M	$5.831M
YoY Change	272.36%	227.63%	1.92%
% of Operating Profit	93.06%	159.86%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.432M	-$6.646M	-$15.84M
YoY Change	-84.15%	-160.47%	-202.38%
Income Tax	$975.0K	-$1.455M	-$2.773M
% Of Pretax Income	68.09%
Net Earnings	$457.0K	-$5.191M	-$13.07M
YoY Change	-94.32%	-107.13%	-183.44%
Net Earnings / Revenue	0.36%	-4.2%	-15.6%
Basic Earnings Per Share	$0.01	-$0.15	-$0.39
Diluted Earnings Per Share	$0.01	-$0.15	-$0.39
COMMON SHARES
Basic Shares Outstanding	34.13M	34.00M	33.67M
Diluted Shares Outstanding	34.57M	34.00M	33.67M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$134.1M	$122.7M	$106.7M
YoY Change	-30.59%	-39.48%	-41.63%
Cash & Equivalents	$134.1M	$122.7M	$106.7M
Short-Term Investments
Other Short-Term Assets	$11.04M	$11.78M	$10.45M
YoY Change	203.19%	94.1%	113.24%
Inventory	$64.65M	$77.77M	$80.15M
Prepaid Expenses
Receivables	$195.4M	$197.5M	$166.3M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$405.2M	$409.8M	$363.6M
YoY Change	11.56%	28.64%	22.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$19.74M	$19.97M	$20.20M
YoY Change	0.59%	2.1%	2.24%
Goodwill	$130.1M	$130.1M	$131.5M
YoY Change
Intangibles	$609.7M	$647.3M	$694.8M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$57.00K	$67.00K	$77.00K
YoY Change	470.0%	-41.74%	-40.31%
Total Long-Term Assets	$795.7M	$835.8M	$882.5M
YoY Change	110.19%	111.49%	152.32%
TOTAL ASSETS
Total Short-Term Assets	$405.2M	$409.8M	$363.6M
Total Long-Term Assets	$795.7M	$835.8M	$882.5M
Total Assets	$1.201B	$1.246B	$1.246B
YoY Change	61.89%	74.51%	92.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.637M	$6.627M	$3.851M
YoY Change	-1.2%	-12.14%	-55.56%
Accrued Expenses	$22.80M	$39.70M	$41.07M
YoY Change	10.7%	44.98%	143.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$141.7M	$120.8M	$100.0M
YoY Change	194.31%	152.16%	109.64%
Total Short-Term Liabilities	$414.5M	$415.1M	$373.6M
YoY Change	54.1%	82.99%	62.3%
LONG-TERM LIABILITIES
Long-Term Debt	$581.9M	$625.3M	$668.6M
YoY Change	172.46%	177.34%	181.74%
Other Long-Term Liabilities	$7.347M	$7.600M	$7.913M
YoY Change	-10.03%	-9.21%	-7.99%
Total Long-Term Liabilities	$589.2M	$632.9M	$676.5M
YoY Change	165.74%	170.66%	175.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$414.5M	$415.1M	$373.6M
Total Long-Term Liabilities	$589.2M	$632.9M	$676.5M
Total Liabilities	$1.004B	$1.048B	$1.050B
YoY Change	104.55%	127.49%	120.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$274.1M	-$274.6M	-$269.4M
YoY Change	18.52%	14.73%	-13.7%
Common Stock	$37.00K	$37.00K	$36.00K
YoY Change	2.78%	2.78%	2.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$47.86M	$47.86M
YoY Change
Treasury Stock Shares		$2.458M	$2.458M
Shareholders Equity	$197.2M	$197.6M	$196.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.201B	$1.246B	$1.246B
YoY Change	61.89%	74.51%	92.88%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$457.0K	-$5.191M	-$13.07M
YoY Change	-94.32%	-107.13%	-183.44%
Depreciation, Depletion And Amortization	$38.04M	$38.16M	$715.0K
YoY Change	120.6%	121.15%	62.87%
Cash From Operating Activities	$42.77M	$40.45M	-$25.32M
YoY Change	147.88%	37.1%	-223.07%
INVESTING ACTIVITIES
Capital Expenditures	-$113.0K	-$461.0K	$108.0K
YoY Change	-59.06%	-38.78%	-74.77%
Acquisitions			$572.1M
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$113.0K	-$461.0K	-$572.2M
YoY Change	-59.06%	-38.78%	133586.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-31.25M	-23.97M	517.8M
YoY Change	17.9%	172.43%	-4614.86%
NET CHANGE
Cash From Operating Activities	42.77M	40.45M	-25.32M
Cash From Investing Activities	-113.0K	-461.0K	-572.2M
Cash From Financing Activities	-31.25M	-23.97M	517.8M
Net Change In Cash	11.40M	16.02M	-79.73M
YoY Change	-219.66%	-19.7%	-1019.16%
FREE CASH FLOW
Cash From Operating Activities	$42.77M	$40.45M	-$25.32M
Capital Expenditures	-$113.0K	-$461.0K	$108.0K
Free Cash Flow	$42.88M	$40.91M	-$25.42M
YoY Change	144.62%	35.21%	-226.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	308871000
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q2	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2022Q2	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2021Q2	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2022Q2	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021Q4	us-gaap	Inventory Net InventoryNet	17394000
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q2	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q2	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0
CY2022Q2	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11778000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5879000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021Q2	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q2	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q2	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001267565
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37372
	dei	Entity Registrant Name EntityRegistrantName	Collegium Pharmaceutical, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	03-0416362
	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 Technology Center Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Stoughton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02072
	dei	City Area Code CityAreaCode	781
	dei	Local Phone Number LocalPhoneNumber	713-3699
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	COLL
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34126205
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122722000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	186426000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	197505000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	105844000
CY2022Q2	us-gaap	Inventory Net InventoryNet	77769000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	268723000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	409774000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	315543000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19965000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19491000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7257000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7644000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	647299000
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2547000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2547000
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	28571000
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	78042000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	67000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	87000
CY2022Q2	us-gaap	Goodwill Goodwill	130094000
CY2022Q2	us-gaap	Assets Assets	1245574000
CY2021Q4	us-gaap	Assets Assets	692077000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6627000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4189000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	39704000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29214000
CY2022Q2	coll	Accrued Rebates Returns And Discounts Current AccruedRebatesReturnsAndDiscountsCurrent	246719000
CY2021Q4	coll	Accrued Rebates Returns And Discounts Current AccruedRebatesReturnsAndDiscountsCurrent	196996000
CY2022Q2	us-gaap	Loans Payable Current LoansPayableCurrent	120833000
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	48353000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1211000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	814000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	415094000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	279566000
CY2022Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	484853000
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	61666000
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	140415000
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	139966000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7600000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7951000
CY2022Q2	us-gaap	Liabilities Liabilities	1047962000
CY2021Q4	us-gaap	Liabilities Liabilities	489149000
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36567830
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34109981
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35806119
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33655402
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	37000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	36000
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	47861000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26465000
CY2021Q2	us-gaap	Interest Expense InterestExpense	5421000
	us-gaap	Interest Expense InterestExpense	23592000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	520038000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	502095000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274602000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-256342000
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	2457849
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2150717
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	42861000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	197612000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	202928000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1245574000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	692077000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	123549000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	82942000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	207300000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	170663000
CY2022Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	33684000
CY2021Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	15908000
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	50016000
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	31236000
CY2022Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	37501000
CY2021Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	16795000
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	56424000
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	33590000
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	71185000
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32703000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	106440000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	64826000
CY2022Q2	us-gaap	Gross Profit GrossProfit	52364000
CY2021Q2	us-gaap	Gross Profit GrossProfit	50239000
	us-gaap	Gross Profit GrossProfit	100860000
	us-gaap	Gross Profit GrossProfit	105837000
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3462000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3983000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6392000
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	41254000
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30368000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	95782000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	61844000
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	41254000
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	33830000
	us-gaap	Operating Expenses OperatingExpenses	99765000
	us-gaap	Operating Expenses OperatingExpenses	68236000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	11110000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	16409000
	us-gaap	Operating Income Loss OperatingIncomeLoss	1095000
	us-gaap	Operating Income Loss OperatingIncomeLoss	37601000
CY2022Q2	us-gaap	Interest Expense InterestExpense	17761000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1455000
	us-gaap	Interest Expense InterestExpense	11142000
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	5000
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	203000
CY2021Q2	us-gaap	Investment Income Net InvestmentIncomeNet	3000
	us-gaap	Investment Income Net InvestmentIncomeNet	9000
	us-gaap	Investment Income Net InvestmentIncomeNet	6000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6646000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10991000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22488000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-61852000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4228000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-62040000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5191000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	72843000
	us-gaap	Net Income Loss NetIncomeLoss	-18260000
	us-gaap	Net Income Loss NetIncomeLoss	88505000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.52
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34001553
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35302608
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33838638
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35128144
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.20
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34001553
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41286853
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33838638
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41251749
	us-gaap	Profit Loss ProfitLoss	-18260000
	us-gaap	Profit Loss ProfitLoss	88505000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56424000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33590000
	us-gaap	Depreciation Depreciation	1371000
	us-gaap	Depreciation Depreciation	864000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9410000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-62649000
	us-gaap	Share Based Compensation ShareBasedCompensation	11827000
	us-gaap	Share Based Compensation ShareBasedCompensation	13395000
	coll	Operating Lease Payments Non Cash OperatingLeasePaymentsNonCash	429000
	coll	Operating Lease Payments Non Cash OperatingLeasePaymentsNonCash	15000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3435000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1795000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36165000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6778000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-17007000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4498000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-245000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1301000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2426000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	50105000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	569000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1153000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2472000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7659000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2969000
	coll	Increase Decrease In Accrued Rebates Returns And Discounts IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts	-6538000
	coll	Increase Decrease In Accrued Rebates Returns And Discounts IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts	-13330000
	coll	Increase Decrease In Operating Lease Asset And Liabilities IncreaseDecreaseInOperatingLeaseAssetAndLiabilities	4000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15136000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	572069000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-572638000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1153000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	203000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	358000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4806000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8274000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3893000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3929000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	25000000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	25000000
	coll	Proceeds From Term Note Modification ProceedsFromTermNoteModification	517682000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	493798000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20297000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-63704000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	28655000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188973000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176663000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125269000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	205318000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122722000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	202771000
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2547000
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2547000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125269000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	205318000
	us-gaap	Interest Paid Net InterestPaidNet	17752000
	us-gaap	Interest Paid Net InterestPaidNet	9348000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6776000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	876000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	105000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	55000
	coll	Inventory Used In Construction And Installation Of Property And Equipment InventoryUsedInConstructionAndInstallationOfPropertyAndEquipment	516000
	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	true
	coll	Returns Policy Threshold Product Return Period ReturnsPolicyThresholdProductReturnPeriod	P18M
	coll	Returns Policy Threshold Product Return Period Prior To Expiration ReturnsPolicyThresholdProductReturnPeriodPriorToExpiration	P6M
	coll	Returns Policy Threshold Product Return Period After Expiration ReturnsPolicyThresholdProductReturnPeriodAfterExpiration	P12M
CY2021	coll	Maximum Percentage Of Actual Return To Returns Claimed MaximumPercentageOfActualReturnToReturnsClaimed	0.20
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	123549000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	82942000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	207300000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	170663000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5191000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	72843000
	us-gaap	Net Income Loss NetIncomeLoss	-18260000
	us-gaap	Net Income Loss NetIncomeLoss	88505000
CY2021Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	1168000
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	2333000
CY2022Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-5191000
CY2021Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	74011000
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-18260000
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	90838000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34001553
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35302608
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33838638
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35128144
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34001553
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41286853
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33838638
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41251749
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.52
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.79
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.20
CY2021Q2	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0
CY2022Q2	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0
CY2022Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	119492000
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	140415000
CY2022Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	625000000
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	7914000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3685000
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	46427000
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1007000
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	23428000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	12702000
CY2022Q2	us-gaap	Inventory Net InventoryNet	77769000
CY2021Q4	us-gaap	Inventory Net InventoryNet	17394000
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	130094000
CY2022Q2	us-gaap	Goodwill Goodwill	130094000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	956170000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	196076000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	647299000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	521170000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	252447000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	268723000
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1545000
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37501000
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16795000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56424000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33590000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	75104000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	150211000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	150211000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	150210000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	83030000
CY2022Q2	coll	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	38533000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	647299000
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000
CY2022Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	13692000
CY2021Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	9930000
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	9000000
CY2022Q2	coll	Accrued Product Taxes And Fees Current AccruedProductTaxesAndFeesCurrent	3421000
CY2021Q4	coll	Accrued Product Taxes And Fees Current AccruedProductTaxesAndFeesCurrent	2570000
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2396000
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2634000
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2116000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3623000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1969000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	807000
CY2022Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1555000
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	697000
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1415000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1415000
CY2022Q2	coll	Accrued Incentive Compensation Current AccruedIncentiveCompensationCurrent	1054000
CY2021Q4	coll	Accrued Incentive Compensation Current AccruedIncentiveCompensationCurrent	851000
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	622000
CY2021Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3222000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3086000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2843000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	39704000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29214000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	202928000
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3261000
CY2022Q1	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue	-3382000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6135000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-13069000
CY2022Q2	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue	-511000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5692000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5191000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	197612000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	186031000
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4102000
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	358000
CY2021Q1	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue	-3508000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6879000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	15662000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	170035000
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4093000
CY2021Q2	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue	-421000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6516000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	72843000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	253066000
CY2021Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000
CY2021Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5692000
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6516000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11827000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13395000
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	43096000
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2021Q4	us-gaap	Loss Contingency Claims Settled Number LossContingencyClaimsSettledNumber	27
CY2022Q2	us-gaap	Loss Contingency Claims Dismissed Number LossContingencyClaimsDismissedNumber	8
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1455000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-61852000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4228000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-62040000
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.219
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-5.628
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.188
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-2.344

Files In Submission

Name	View Source	Status
0001558370-22-012184-index-headers.html	Edgar Link	pending
0001558370-22-012184-index.html	Edgar Link	pending
0001558370-22-012184.txt	Edgar Link	pending
0001558370-22-012184-xbrl.zip	Edgar Link	pending
coll-20220630.xsd	Edgar Link	pending
coll-20220630x10q.htm	Edgar Link	pending
coll-20220630x10q001.jpg	Edgar Link	pending
coll-20220630x10q_htm.xml	Edgar Link	completed
coll-20220630xex31d1.htm	Edgar Link	pending
coll-20220630xex31d2.htm	Edgar Link	pending
coll-20220630xex32d1.htm	Edgar Link	pending
coll-20220630xex32d2.htm	Edgar Link	pending
coll-20220630_cal.xml	Edgar Link	unprocessable
coll-20220630_def.xml	Edgar Link	unprocessable
coll-20220630_lab.xml	Edgar Link	unprocessable
coll-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COLL
COLLEGIUM PHARMACEUTICAL, INC Stock $coll

2022 Q3 Form 10-Q Financial Statement

#000155837022012184 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COLL COLLEGIUM PHARMACEUTICAL, INC Stock $coll

2022 Q3 Form 10-Q Financial Statement

#000155837022012184 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COLL
COLLEGIUM PHARMACEUTICAL, INC Stock $coll